Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001). | |
Wang, Wen Xian; Xu, Chun-Wei; Li, Ziming; Song, Zhengbo; Fang, Wenfeng; Miao, Liyun; Zhu, You-Cai; Zhang, Shirong; Song, Bin-Bin; Shi, Xue-Fei | |
刊名 | JOURNAL OF CLINICAL ONCOLOGY |
2021-05-20 | |
卷号 | 39 |
ISSN号 | 0732-183X |
DOI | 10.1200/JCO.2021.39.15_suppl.e21036 |
WOS研究方向 | Oncology |
语种 | 英语 |
出版者 | LIPPINCOTT WILLIAMS & WILKINS |
WOS记录号 | WOS:000708120305037 |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126512] |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Jiaxing Univ, Dept Med Oncol, Affiliated Hosp, Jiaxing, Peoples R China 2.Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou, Peoples R China 3.Univ Chinese Acad Sci, Chinese Acad Sci, Inst Canc Res & Basic Med Sci, Zhejiang Canc Hosp,Dept Med Oncol,Canc Hosp, Hangzhou, Peoples R China 4.Nanjing Univ, Dept Resp Med, Affiliated Jinling Hosp, Med Sch, Nanjing, Peoples R China 5.Shanghai Jiao Tong Univ, Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China 6.Zhejiang Canc Hosp, Hangzhou, Peoples R China 7.Ningbo 2 Hosp, Dept Radiotherapy, Ningbo, Peoples R China 8.Zhebei Mingzhou Hosp, Huzhou, Peoples R China 9.Huzhou Cent Hosp, Dept Resp Med, Huzhou, Peoples R China 10.Zhejiang Univ, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejian, Affiliated Hangzhou Peoples Hosp 1, Translat Med Res Ctr,Sch Med, Hangzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Wen Xian,Xu, Chun-Wei,Li, Ziming,et al. Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
APA | Wang, Wen Xian.,Xu, Chun-Wei.,Li, Ziming.,Song, Zhengbo.,Fang, Wenfeng.,...&Lu, Shun.(2021).Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001)..JOURNAL OF CLINICAL ONCOLOGY,39. |
MLA | Wang, Wen Xian,et al."Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing-A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论